Kyle Dempsey
Direktor/Vorstandsmitglied bei OPTINOSE, INC.
Vermögen: 6 089 $ am 30.04.2024
Profil
Kyle Dempsey currently works at OptiNose, Inc., as Independent Director from 2021, GT Medical Technologies, Inc., as Director, HLS Therapeutics, Inc., as Independent Director from 2022, and MVM Partners LLC, as Partner from 2017.
Dr. Dempsey received his undergraduate degree from Bowdoin College, doctorate degree from Harvard Medical School, and Masters Business Admin degree from Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HLS THERAPEUTICS, INC.
0,01% | 31.03.2024 | 1 765 ( 0,01% ) | 6 089 $ | 30.04.2024 |
OPTINOSE, INC.
-.--% | 08.06.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Kyle Dempsey
| Unternehmen | Position | Beginn |
|---|---|---|
| OPTINOSE, INC. | Direktor/Vorstandsmitglied | 10.12.2021 |
| HLS THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 29.11.2022 |
| MVM Partners LLC | Private Equity Investor | 01.09.2017 |
GT Medical Technologies, Inc.
 GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology GT Medical Technologies, Inc. engages in the design and development of a medical device for the treatment of brain tumors. It offers GammaTile Therapy, which is a surgically targeted radiation therapy which is placed at the end if a brain excision surgery and targets residual tumor cells. The company was founded by Heyoung McBride, Peter Nakaji, Emad Youssef, and Theresa Thomas in 2017 and is headquartered in Tempe, AZ. | Direktor/Vorstandsmitglied | - |
Ausbildung von Kyle Dempsey
| Harvard Medical School | Doctorate Degree |
| Bowdoin College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| HLS THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| MVM Partners LLC | Finance |
GT Medical Technologies, Inc.
GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology GT Medical Technologies, Inc. engages in the design and development of a medical device for the treatment of brain tumors. It offers GammaTile Therapy, which is a surgically targeted radiation therapy which is placed at the end if a brain excision surgery and targets residual tumor cells. The company was founded by Heyoung McBride, Peter Nakaji, Emad Youssef, and Theresa Thomas in 2017 and is headquartered in Tempe, AZ. | Health Technology |
